Danaher Corporation $DHR Stock Position Lowered by State of Wisconsin Investment Board

State of Wisconsin Investment Board lessened its position in Danaher Corporation (NYSE:DHR) by 1.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 336,576 shares of the conglomerate’s stock after selling 5,599 shares during the quarter. State of Wisconsin Investment Board’s holdings in Danaher were worth $77,049,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in DHR. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the 3rd quarter valued at approximately $25,000. Elevated Capital Advisors LLC purchased a new stake in Danaher in the 4th quarter worth approximately $26,000. WFA of San Diego LLC purchased a new stake in Danaher in the 2nd quarter worth approximately $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher in the 3rd quarter worth approximately $27,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher in the 4th quarter worth approximately $27,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $181.57 on Wednesday. The company’s fifty day moving average is $180.54 and its 200-day moving average is $203.94. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm has a market cap of $128.51 billion, a price-to-earnings ratio of 35.12, a price-to-earnings-growth ratio of 2.31 and a beta of 0.81. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter in the prior year, the business posted $1.88 EPS. Danaher’s quarterly revenue was up 3.7% on a year-over-year basis. Equities analysts expect that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio is 30.95%.

Wall Street Analyst Weigh In

DHR has been the subject of a number of research analyst reports. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price for the company. JPMorgan Chase & Co. cut their target price on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Royal Bank Of Canada initiated coverage on shares of Danaher in a research report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 target price for the company. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $233.61.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.